140 related articles for article (PubMed ID: 38193579)
1. Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction.
Masson D; Leleu D; Farnier M; Chagué F; Rampon C; Bichat F; Demeule C; Maza M; Pais de Barros JP; Cottin Y; Zeller M
Cardiovasc Res; 2024 Mar; 120(2):111-113. PubMed ID: 38193579
[No Abstract] [Full Text] [Related]
2. Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; Stijnen T; Gemen EF; Kusters R; Giltay EJ
Clin J Am Soc Nephrol; 2014 Oct; 9(10):1676-83. PubMed ID: 25104273
[TBL] [Abstract][Full Text] [Related]
3. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the impact of genetic polymorphisms in glutathione-related genes on the association between methylmercury or n-3 polyunsaturated long chain fatty acids and risk of myocardial infarction: a case-control study.
Engström KS; Wennberg M; Strömberg U; Bergdahl IA; Hallmans G; Jansson JH; Lundh T; Norberg M; Rentschler G; Vessby B; Skerfving S; Broberg K
Environ Health; 2011 Apr; 10():33. PubMed ID: 21504558
[TBL] [Abstract][Full Text] [Related]
5. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
[TBL] [Abstract][Full Text] [Related]
6. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study.
Lemaitre RN; King IB; Mozaffarian D; Kuller LH; Tracy RP; Siscovick DS
Am J Clin Nutr; 2003 Feb; 77(2):319-25. PubMed ID: 12540389
[TBL] [Abstract][Full Text] [Related]
7. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement.
Sarter B; Kelsey KS; Schwartz TA; Harris WS
Clin Nutr; 2015 Apr; 34(2):212-8. PubMed ID: 24679552
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease.
Weisman D; Motro M; Schwammenthal E; Fisman EZ; Tenenbaum A; Tanne D; Adler Y
Isr Med Assoc J; 2004 Apr; 6(4):227-32. PubMed ID: 15115262
[No Abstract] [Full Text] [Related]
9. Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia.
Setty BNY; Betal SG; Miller RE; Brown DS; Meier M; Cahill M; Lerner NB; Apollonsky N; Stuart MJ
Prostaglandins Leukot Essent Fatty Acids; 2019 Jul; 146():11-18. PubMed ID: 31186149
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both?
von Schacky C
Curr Opin Clin Nutr Metab Care; 2008 Mar; 11(2):94-9. PubMed ID: 18301082
[TBL] [Abstract][Full Text] [Related]
11. [Omega-3 fatty acids in secondary prevention after myocardial infarct].
Rupp H
Clin Res Cardiol; 2006; 95 Suppl 6():VI12-6. PubMed ID: 17013579
[TBL] [Abstract][Full Text] [Related]
12. Supplementation with omega-3 acids after myocardial infarction and modification of inflammatory markers in light of the patients' diet: a preliminary study.
Makarewicz-Wujec M; Parol G; Parzonko A; Kozłowska-Wojciechowska M
Kardiol Pol; 2017; 75(7):674-681. PubMed ID: 28394002
[TBL] [Abstract][Full Text] [Related]
13. [The Alpha Omega study].
Trimarco B; Tavazzi L; Marchioli R
G Ital Cardiol (Rome); 2011; 12(7-8):469-73. PubMed ID: 21779112
[No Abstract] [Full Text] [Related]
14. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids.
Billman GE; Hallaq H; Leaf A
Proc Natl Acad Sci U S A; 1994 May; 91(10):4427-30. PubMed ID: 8183925
[TBL] [Abstract][Full Text] [Related]
15. Blood eicosapentaenoic acid and docosahexaenoic acid as predictors of all-cause mortality in patients with acute myocardial infarction--data from Infarction Prognosis Study (IPS) Registry.
Lee SH; Shin MJ; Kim JS; Ko YG; Kang SM; Choi D; Jang Y; Chung N; Shim WH; Cho SY; Manabe I; Ha JW
Circ J; 2009 Dec; 73(12):2250-7. PubMed ID: 19789416
[TBL] [Abstract][Full Text] [Related]
16. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
17. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
18. [Omega-3 fatty acids in cardiology. Latest developments].
von Schacky C
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():97-101. PubMed ID: 17955786
[TBL] [Abstract][Full Text] [Related]
19. [Confusion about the effects of omega-3 fatty acids : Contemplation of study data taking the omega-3 index into consideration].
von Schacky C
Internist (Berl); 2019 Dec; 60(12):1319-1327. PubMed ID: 31591673
[TBL] [Abstract][Full Text] [Related]
20. Effect of omega-3 fatty acids, docosahexaenoic and eicosapentaenoic, on norepinephrine-induced contractions.
Engler MB
Can J Physiol Pharmacol; 1992 May; 70(5):675-9. PubMed ID: 1423009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
